Ainos (OTCMKTS:AIMD) Trading Up 0.3% – Still a Buy?

Ainos, Inc. (OTCMKTS:AIMD)’s share price traded up 0.3% during mid-day trading on Wednesday . The company traded as high as $1.9181 and last traded at $1.9160. 10,184 shares changed hands during trading, a decline of 51% from the average session volume of 20,954 shares. The stock had previously closed at $1.91.

Ainos Price Performance

The company has a debt-to-equity ratio of 0.08, a current ratio of 1.92 and a quick ratio of 1.45. The firm has a market capitalization of $9.22 million, a price-to-earnings ratio of -2.20 and a beta of 2.45. The business’s fifty day simple moving average is $2.12 and its 200 day simple moving average is $2.94.

About Ainos

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.